| Literature DB >> 35488986 |
Taha Ismail1, Elsayed Hegazi2, Eldsokey Nassef2, Ola A Habotta3, Mahmoud S Gewaily4.
Abstract
A 95-day feeding trial was conducted to evaluate the outcomes of feeding Bacillus subtilis fermented Azolla (BSFA) on nonspecific immunity, antioxidative status, intestinal digestive enzymes and histomorphometry, and disease resistance in the Nile tilapia. We formulated five isonitrogenous and isocaloric experimental diets to incorporate BSFA at level of (0%, 15%, 30%, 45%, 60%). The growth performance parameters (FBW, BWG, SGR, PER, and FCR) revealed a significant increase in the BSFA30 tilapia group compared to the control group followed by BSFA45 (P < 0.05). The BSFA30 group exhibited the highest nonspecific immunity parameters including (lysozyme activity, phagocytic index, and phagocytic activity) compared to other groups (P < 0.05). SOD and GPx reported the highest values in the BSFA60 group. Nile tilapia carcass composition was not influenced by BSFA inclusion level (P > 0.05). Interestingly, Nile tilapia fed with BSFA15 diet exhibited the highest protease activity level (P < 0.05), while those fed on BSFA30 documented the highest amylase activity. Intestinal histomorphology was significantly enhanced with the gradual increase of administrated BSFA. Regarding the tilapia disease resistance against Aeromonas septicemia, BSFA significantly diminished the cumulative mortality compared to the control group. To sum up, BSFA was more effective in improving the growth performance and immunity of Nile tilapia.Entities:
Keywords: Antioxidative status; Azolla pinnata; Intestinal digestive enzymes; Nile tilapia; Solid state fermentation
Mesh:
Substances:
Year: 2022 PMID: 35488986 PMCID: PMC9156518 DOI: 10.1007/s10695-022-01076-2
Source DB: PubMed Journal: Fish Physiol Biochem ISSN: 0920-1742 Impact factor: 3.014
Ration formulation of experimental diets
| Ingredient (%) | BSFA (%) | ||||
|---|---|---|---|---|---|
| 0 | 15 | 30 | 45 | 60 | |
| FM1 | 9 | 9 | 9 | 9 | 9 |
| SBM2 | 22 | 18 | 18 | 16 | 13 |
| CGM3 | 14 | 14 | 10.5 | 9 | 8 |
| wheat bran | 14.32 | 10.42 | 8 | 4.8 | 1 |
| BSFA4 | 0 | 15 | 30 | 45 | 60 |
| Maize | 15.5 | 11 | 8.5 | 4.86 | 2 |
| rice polish | 16.55 | 13.05 | 8.13 | 5 | 1.35 |
| α-cellulose | 4.68 | 4.68 | 3.12 | 1.7 | 0.4 |
| Oil | 1.5 | 2.5 | 2.5 | 2.5 | 3.1 |
| Mineral* | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Vitamins** | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Vitamin C | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| NaCl | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Antimycotoxin | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| CMC5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Dicalcium P | 1 | 1 | 1 | 1 | 1 |
| DL-Methionine | 0.3 | 0.1 | 0.1 | 0.04 | 0.1 |
| Lysine-HCl | 0.2 | 0.2 | 0.2 | 0.15 | 0.1 |
| L-Threonine | 0 | 0.1 | 0 | 0 | 0 |
1Moroccan fish meal 63% CP, 2soybean meal 48% CP, 3corn gluten meal 60%CP, 4Bacillus subtilis fermented Azolla 22.3% CP, 5xarboxy methyl cellulose. *Minerals (Egypt pharma company) each 1.25 kg of this product provide the following: 5000 mg copper; 5 mg cobalt; 5000 mg iodine; 100 mg selenium; 30,000 mg iron; 40,000 mg magnesium; 10,000 mg manganese; 150,000 mg zinc; calcium carbonate ad to 1000 gm. **Vitamins (Egypt pharma company) each 1.25 kg of this product provide the following: 5,000,000 IU Vit. A; 1,000,000 IU Vit. D3; 50,000 mg Vit. E; 10,000 mg K3; 20,000 mg B1; 20,000 mg B2; 20,000 mg B6; 20 mg B12; 100,000 mg niacin; 5000 mg folic; 100 mg biotin; 50,000 mg pantothenic acid; calcium carbonate ad to1000 gm
Chemical analysis of experimental diets
| Items | AM* | BSFA** | BSFA (%) | ||||
|---|---|---|---|---|---|---|---|
| 0 | 15 | 30 | 45 | 60 | |||
| CP% | 21.5 | 22.3 | 30.18 | 30.22 | 30.17 | 30.46 | 30.47 |
| EE% | 3.8 | 3.5 | 6.45 | 6.95 | 6.37 | 6.04 | 6.19 |
| Ash% | 15.9 | 16.5 | 5.19 | 6.85 | 8.73 | 10.59 | 12.31 |
| NDF% | 35.55 | 31.43 | 8.93 | 9.79 | 10.03 | 10.37 | 10.87 |
| Gross energy (kJ kg−1)1 | 1405.62 | 1427.59 | 1816.73 | 1788.65 | 1765.17 | 1768.63 | 1752.62 |
| Amino acids (g 100g−1 DM) | |||||||
| Arginine | 1.13 | 1.53 | 1.67 | 1.57 | 1.75 | 1.86 | 1.89 |
| Histidine | 0.45 | 0.43 | 0.74 | 0.72 | 0.71 | 0.71 | 0.69 |
| Isoleucine | 0.93 | 0.95 | 1.30 | 1.29 | 1.32 | 1.34 | 1.34 |
| Leucine | 1.55 | 1.60 | 2.94 | 2.29 | 2.74 | 2.72 | 2.66 |
| Methionine | 0.44 | 0.56 | 0.96 | 0.80 | 0.79 | 0.76 | 0.85 |
| Lysine | 0.99 | 0.96 | 1.40 | 1.40 | 1.47 | 1.48 | 1.47 |
| Phenylalanine | 1.01 | 0.98 | 1.13 | 1.19 | 1.15 | 1.20 | 1.23 |
| Threonine | 0.88 | 0.93 | 1.12 | 1.23 | 1.17 | 1.21 | 1.23 |
| Valine | 1.19 | 1.27 | 1.51 | 1.55 | 1.56 | 1.61 | 1.63 |
1Gross energy calculated using gross calorific values of 23.63, 39.52, and 17.15 kJ g−1 for protein, fat, and carbohydrate, respectively as recorded by (Brett, 1973). *Azolla meal. **Bacillus subtilis-fermented Azolla
Growth parameters, feed utilization and somatic indices of Nile tilapia fed Bacillus subtilis fermented Azolla for 95 days
| Items | BSFA (%) | ||||
|---|---|---|---|---|---|
| 0 | 15 | 30 | 45 | 60 | |
| IW (g) | 15.60 ± 0.15 | 15.50 ± 0.17 | 15.60 ± 0.17 | 16.03 ± 0.35 | 15.80 ± 0.21 |
| FBW (g) | 58.17 ± 0.91c | 58.38 ± 0.72c | 65.83 ± 0.35a | 61.27 ± 0.39b | 56.10 ± 0.36d |
| FI (g fish−1) | 66.42 ± 0.62c | 65.88 ± 0.59c | 71.09 ± 0.63a | 69.17 ± 0.63b | 64.46 ± 0.31d |
| BWG (%) | 272.82 ± 2.18b | 276.71 ± 4.76b | 322.06 ± 2.47a | 282.49 ± 8.85b | 255.13 ± 2.42c |
| FCR | 1.56 ± 0.01b | 1.54 ± 0.02b | 1.42 ± 0.01c | 1.53 ± 0.01b | 1.59 ± 0.02a |
| SGR | 1.38 ± 0.01c | 1.39 ± 0.02c | 1.52 ± 0.01a | 1.44 ± 0.02b | 1.33 ± 0.01d |
| PER | 2.14 ± 0.02bc | 2.17 ± 0.02b | 2.35 ± 0.02a | 2.18 ± 0.01b | 2.08 ± 0.02c |
| Survival (%) | 95.00 ± 2.89 | 96.10 ± 2.01 | 96.67 ± 1.67 | 96.67 ± 1.67 | 93.33 ± 1.67 |
| HIS | 1.43 ± 0.07 | 1.49 ± 0.16 | 1.38 ± 0.04 | 1.40 ± 0.04 | 1.53 ± 0.07 |
| VSI | 5.19 ± 0.07 | 5.49 ± 0.14 | 5.26 ± 0.24 | 5.15 ± 0.50 | 6.10 ± 0.26 |
*Values are means ± standard error (n = 3). Means with different small letter in the same column differ significantly (P < 0.05). IW, initial weight; FBW, final body weight; BWG, body weight gain; ADG, average daily gain; FI, feed intake; FCR, feed conversion ratio; SGR, specific growth rate; PER, protein efficiency ratio; HSI, hepatosomatic index; VSI, viscerosomatic index
Regression analysis based on different parameters of Nile tilapia fed Bacillus subtilis fermented Azolla for 95 days*
| Item | Regression equation | Optimal dose (%) | |
|---|---|---|---|
| FCR | 29.22 | ||
| FI (g fish−1) | 29.92 | ||
| BWG (g) | 29.82 | ||
| FBW (g) | 30.10 | ||
| SGR | 29.11 | ||
| PER | 28.86 | ||
| Lysozyme activity (U/ml) | 29.95 | ||
| Phagocytic activity (%) | 29.01 | ||
| Phagocytic index | 29.12 | ||
| SOD (U/ml) | 12.03 | ||
| GPx (mU/mL) | 18.55 | ||
| Amylase activity (U/mg protein | 25.66 | ||
| Protease activity (U/mg protein) | 22.85 |
*The parameters showed significant differences (P < 0.05) are selected to be represented in the table
Hematological and serum biochemical parameters of Nile tilapia fed Bacillus subtilis fermented Azolla for 95 days
| Items | BSFA (%) | ||||
|---|---|---|---|---|---|
| 0 | 15 | 30 | 45 | 60 | |
| Hb (g/dl) | 5.98 ± 0.37 | 6.38 ± 0.32 | 6.20 ± 0.06 | 6.25 ± 0.02 | 6.10 ± 0.47 |
| RBCs (106/µl) | 2.06 ± 0.08 | 2.26 ± 0.05 | 2.20 ± 0.13 | 2.11 ± 0.03 | 2.21 ± 0.22 |
| Hematocrit (%) | 30.03 ± 0.35 | 30.40 ± 0.60 | 30.08 ± 0.85 | 29.66 ± 0.28 | 29.81 ± 0.18 |
| WBCs (103/µl) | 37.75 ± 0.66 | 37.07 ± 1.02 | 37.95 ± 0.50 | 37.59 ± 1.25 | 37.00 ± 0.39 |
| Total protein (g/dl) | 2.52 ± 0.01 | 2.59 ± 0.06 | 2.61 ± 0.10 | 2.57 ± 0.04 | 2.61 ± 0.06 |
| ALT (U/L) | 31.38 ± 0.32 | 31.53 ± 0.37 | 32.53 ± 0.65 | 31.16 ± 0.54 | 32.30 ± 0.65 |
| AST (U/L) | 188.57 ± 2.96 | 187.67 ± 2.19 | 190.67 ± 2.33 | 188.35 ± 1.86 | 186.33 ± 1.45 |
| Creatinine (mg/dl) | 0.25 ± 0.01 | 0.24 ± 0.02 | 0.23 ± 0.02 | 0.23 ± 0.01 | 0.24 ± 0.01 |
Values are means ± standard error (n = 3). Means with different small letter in the same column differ significantly (P < 0.05). Hb, hemoglobin; RBCs, red blood cells; WBCs; white blood cells; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase
Immunological response and oxidative status of Nile tilapia fed Bacillus subtilis fermented Azolla for 95 days
| Items | BSFA (%) | ||||
|---|---|---|---|---|---|
| 0 | 15 | 30 | 45 | 60 | |
| Lysozyme activity (U/ml) | 136.14 ± 4.02cd | 156.47 ± 4.65ab | 170.03 ± 5.55a | 142.13 ± 4.59bc | 125.40 ± 5.14d |
| Phagocytic activity (%) | 45.80 ± 0.29c | 46.99 ± 0.36c | 59.82 ± 0.55a | 51.58 ± 0.71b | 40.40 ± 0.48d |
| Phagocytic index | 2.33 ± 0.08c | 2.33 ± 0.07c | 2.70 ± 0.04a | 2.50 ± 0.03b | 2.18 ± 0.03c |
| SOD (U/ml) | 4.85 ± 0.13b | 4.87 ± 0.27b | 4.84 ± 0.24b | 5.08 ± 0.12ab | 5.27 ± 0.19a |
| GPx (mU/mL) | 0.24 ± 0.01b | 0.21 ± 0.02b | 0.25 ± 0.04b | 0.26 ± 0.01b | 0.32 ± 0.12a |
| MDA (mmol/mL) | 10.80 ± 1.18 | 10.44 ± 0.43 | 10.36 ± 0.56 | 10.36 ± 0.64 | 10.50 ± 1.35 |
Values are means ± standard error (n = 3). Means with different small letter in the same column differ significantly (P < 0.05)
Proximate chemical analysis of Nile tilapia fed Bacillus subtilis fermented Azolla for 95 days
| Items | AM* | BSFA** | BSFA (%) | ||||
|---|---|---|---|---|---|---|---|
| 0 | 15 | 30 | 45 | 60 | |||
| CP% | 21.5 | 22.3 | 30.18 | 30.22 | 30.17 | 30.46 | 30.47 |
| EE% | 3.8 | 3.5 | 6.45 | 6.95 | 6.37 | 6.04 | 6.19 |
| Ash% | 15.9 | 16.5 | 5.19 | 6.85 | 8.73 | 10.59 | 12.31 |
| NDF% | 35.55 | 31.43 | 8.93 | 9.79 | 10.03 | 10.37 | 10.87 |
| Gross energy (kJ kg−1)1 | 1405.62 | 1427.59 | 1816.73 | 1788.65 | 1765.17 | 1768.63 | 1752.62 |
| Amino acids (g 100g−1 DM) | |||||||
| Arginine | 1.13 | 1.53 | 1.67 | 1.57 | 1.75 | 1.86 | 1.89 |
| Histidine | 0.45 | 0.43 | 0.74 | 0.72 | 0.71 | 0.71 | 0.69 |
| Isoleucine | 0.93 | 0.95 | 1.30 | 1.29 | 1.32 | 1.34 | 1.34 |
| Leucine | 1.55 | 1.60 | 2.94 | 2.29 | 2.74 | 2.72 | 2.66 |
| Methionine | 0.44 | 0.56 | 0.96 | 0.80 | 0.79 | 0.76 | 0.85 |
| Lysine | 0.99 | 0.96 | 1.40 | 1.40 | 1.47 | 1.48 | 1.47 |
| Phenylalanine | 1.01 | 0.98 | 1.13 | 1.19 | 1.15 | 1.20 | 1.23 |
| Threonine | 0.88 | 0.93 | 1.12 | 1.23 | 1.17 | 1.21 | 1.23 |
| Valine | 1.19 | 1.27 | 1.51 | 1.55 | 1.56 | 1.61 | 1.63 |
1Gross energy calculated using gross calorific values of 23.63, 39.52, and 17.15 kJ g−1 for protein, fat and carbohydrate, respectively as recorded by (Brett, 1973). *Azolla meal. **Bacillus subtilis-fermented Azolla
Intestinal digestive enzymes activities of Nile tilapia fed Bacillus subtilis fermented Azolla for 95 days
| Items | BSFA (%) | ||||
|---|---|---|---|---|---|
| 0 | 15 | 30 | 45 | 60 | |
| Lipase activity (U/g intestinal content) | 10.20 ± 0.61 | 9.61 ± 0.45 | 9.27 ± 0.66 | 9.56 ± 1.31 | 9.47 ± 0.56 |
| Amylase activity (U/mg protein) | 8.10 ± 0.23b | 7.80 ± 0.37bc | 10.11 ± 0.51a | 7.96 ± 0.37bc | 6.76 ± 0.33c |
| Protease activity (U/mg protein) | 9.20 ± 0.60ab | 10.28 ± 0.79a | 9.27 ± 0.66ab | 9.56 ± 0.43ab | 8.14 ± 0.25b |
Values are means ± standard error (n = 3). Means with different small letter in the same column differ significantly (P < 0.05)
Fig. 1Histomicrograph of Nile tilapia intestine through the anterior, middle, and posterior segments in the control non-treated group as well as BSFA-fed groups (15%, 30%, 45%, and 60% respectively). The histological structures displayed regular arrangement of the layers of intestinal wall and intestinal villi (arrow). There was a noteworthy upgrading in the villus height, villus width, and villus area with increased level of BSFA. Stain H&E. Bar = 200 µm
Fig. 2Histomicrograph of Nile tilapia intestine through the anterior, middle, and posterior segments in the control non-treated group as well as BSFA-fed groups (15%, 30%, 45%, and 60% respectively). The histological structures displayed normal arrangement of PAS-positive goblet cells. The number of goblet cells (arrow) increased all over the entire length of the intestine with increased level of BSFA. Stain PAS. Bar = 200 µm
Fig. 3Effect of dietary Bacillus subtilis fermented Azolla (BSFA) on villus width, villus height, number of goblet cells and villus area of Nile tilapia intestine. Values are means ± standard error (n = 5). Means with different small letter on columns differ significantly (P < 0.05)
Fig. 4A Cutaneous ulcers appear on Nile tilapia body after challenging with A. septicemia (arrow); hemorrhagic patches (arrow) on different parts of the body; B cumulative mortality (%) of Nile tilapia fed graded level of dietary Bacillus subtilis fermented Azolla for 95 days and then challenged with A. septicemia for 14 days